NCT06613828Completed
Efficacy of Five Strategies To Improve Stroke Awareness in the Spanish-Speaking Population
Source: ClinicalTrials.gov · Last updated 1 May 2025
Brief summary (registry, in English)
The goal of this experimental study is to evaluate the efficacy of five educational strategies for recognizing early symptoms of cerebrovascular disease (CVD) in the general adult population. The main questions it aims to answer are: \- How effective are the strategies RAPIDO, CORRE, DALE, CAMALEON, and ICTUS 911 in improving the recognition of early CVD symptoms? Researchers will compare these strategies to determine which one leads to the highest increase in symptom recognition. Participants will receive a brief educational session on one of the five strategies and will: * Complete a pre- and post-intervention survey (Stroke Awareness Questionnaire, SAQ). * Receive short training on CVD symptoms and the urgency of contacting emergency services. The primary outcome is the improvement in SAQ scores, and the secondary outcome is the proportion of participants achieving adequate knowledge of CVD symptoms.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 435 (actual)
- First submitted
- 23 Sept 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 20 Oct 2024
- Lead sponsor
- Instituto Mexicano del Seguro Social
- Diseases
- Stroke
- NCT number
- NCT06613828
What you commit to
- Study type: Interventional
- Participants enrolled: 435
- From 1 Apr 2024 to the primary completion date, 20 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of Stroke: Participants with a previous diagnosis of cerebrovascular disease (stroke) will be excluded.
Other illness
- Cognitive Impairment: Participants who are unable to understand or complete the Stroke Awareness Questionnaire (SAQ) due to cognitive or communication impairments will not be eligible.
Other
- Incomplete Evaluation: Participants who are unable to complete both the pre- and post-intervention assessments will be excluded from the study.
- Elimination Criteria:
- Lack of Follow-Up: Participants who fail to attend the second evaluation (7 days post-intervention) will be excluded from the final analysis.
- Withdrawal of Consent: Participants who choose to withdraw from the study at any time will be eliminated from further participation.
Who the study is looking for
- Age: Participants must be 18 years or older.
- Consent: Participants must provide informed consent to participate in the study.
- General Population: Participants from the general public, regardless of their health insurance status or previous medical history (except as specified in exclusion criteria).
- Language: Participants must be fluent in Spanish, as the educational interventions are based on Spanish-language mnemonic strategies.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital General de Zona #2 Coordinator of this site? Confirm its status | Aguascalientes | Mexico | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.